The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer.
 
Christopher Nutting
Leadership - Advanced Oncotherapy
Stock and Other Ownership Interests - Advanced Oncotherapy
Honoraria - BMSi; GlaxoSmithKline; Merck
 
Keith Rooney
No Relationships to Disclose
 
Bernadette Foran
Honoraria - BMSi
Consulting or Advisory Role - BMSi
Speakers' Bureau - BMSi
Research Funding - BMSi; MSD
Travel, Accommodations, Expenses - BMSi; Merck
 
Laura Pettit
Honoraria - Lilly; Pfizer; Roche
Other Relationship - Eisai
 
Matthew Beasley
No Relationships to Disclose
 
Laura Finneran
Employment - Amgen
Research Funding - AstraZeneca
 
Justin Roe
No Relationships to Disclose
 
Justine Tyler
No Relationships to Disclose
 
Tom Roques
No Relationships to Disclose
 
Audrey Cook
No Relationships to Disclose
 
Imran Petkar
No Relationships to Disclose
 
Shree Bhide
Speakers' Bureau - Elekta
 
Devraj Srinivasan
Honoraria - Bristol-Myers Squibb
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Soligenix (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Cheng Boon
No Relationships to Disclose
 
Emma De Winton
No Relationships to Disclose
 
Robert Frogley
No Relationships to Disclose
 
Kathrin Mertens
Employment - Boehringer Ingelheim
 
Marie Emson
No Relationships to Disclose
 
Emma Hall
Research Funding - Accuray (Inst); Alliance Pharma (Inst); AstraZeneca (Inst); Aventis Pharma (Inst); Bayer (Inst); Kiowa Kirin (Inst); Merck Sharp & Dohme (Inst); Varian Medical Systems (Inst)